Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Opus Genetics, Inc. (IRD) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$10.99M |
|
$-57.53M |
|
-- |
|
$10.99M |
|
$73.07M |
|
$-62.07M |
|
$4.54M |
|
$-57.53M |
|
$-57.53M |
|
$-57.53M |
|
$-57.53M |
|
$-57.53M |
|
$-57.53M |
|
$-62.07M |
|
$-62.06M |
|
26.72M |
|
26.72M |
|
$-2.15 |
|
$-2.15 |
|
| Balance Sheet Financials | |
$36.61M |
|
$0.25M |
|
$0.25M |
|
$36.86M |
|
$11.29M |
|
-- |
|
$18.84M |
|
$30.14M |
|
$6.72M |
|
$6.72M |
|
$6.72M |
|
31.57M |
|
| Cash Flow Statement Financials | |
$-25.58M |
|
$1.21M |
|
$4.19M |
|
$50.50M |
|
$30.32M |
|
$-20.18M |
|
$3.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.24 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-564.72% |
|
-564.72% |
|
-564.63% |
|
-523.40% |
|
-523.40% |
|
$-25.58M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
-- |
|
3.08 |
|
118.31 |
|
-855.62% |
|
-855.62% |
|
-156.07% |
|
-855.62% |
|
$0.21 |
|
$-0.96 |
|
$-0.96 |
|